CD4 and kidney disorder: Second, the NDN patients were included as the control in clinical characteristics and molecular analysis in order to show the influence of CD4+ T cells on the occurrence of DN, but only the high-CD4 and low-CD4 groups of DN patients in pathological and prognostic analysis were compared due to the differences in assessment standards for different renal diseases.